MEDEZE Acknowledges Royal Gazette Announcement on Cell Bank Standards Becomes Thailand’s First Certified Cell Bank, Reinforcing Leadership in Advanced Medical Technologies
MEDEZE Group Public Company Limited (MEDEZE) has officially complied with the Cell Bank Standards announced in the Royal Gazette and has become the first organization in Thailand to receive Cell Bank certification under the Department of Medical Sciences’ Cell Bank Certification Regulations. This achievement reinforces the Company’s position as a leading provider of advanced medical technologies in Thailand.
Dr. Veerapol Khemarangsan,Chief Executive Officer, of MEDEZE Group Public Company Limited, or MEDEZE stated that the Company has become the first certified Cell Bank in Thailand under the Cell Bank Certification Standards established by the Department of Medical Sciences. The regulations were officially published in the Royal Gazette on October 9, 2025. This milestone reflects MEDEZE’s unwavering commitment to developing stem cell technologies in accordance with the highest international standards.
The certification serves as a critical foundation for advancing the development of advanced medical technologies and supporting the growing demand for innovative healthcare solutions in the future.
Currently, technologies related to cell preservation and the utilization of stored cells through cell banking services are rapidly evolving in Thailand. The scope of cell applications has also expanded significantly across medical and public health sectors, including research, healthcare innovation, and other legally permitted purposes. To ensure confidence in the quality, safety, and efficacy of stored cells for medical and public health applications, cell banking operations must adhere to internationally recognized standards. Furthermore, the establishment of certification criteria promotes standardized practices among domestic operators and helps prevent unfair business practices within the industry.
MEDEZE remains the only legally certified stem cell bank in Thailand, offering comprehensive stem cell and immune cell banking services. With years of accumulated expertise and experience, the Company has established itself as a leading provider of personalized stem cell banking services in Southeast Asia.
For individuals seeking a trusted stem cell banking partner, MEDEZE offers internationally recognized standards, including ISO 9001:2015 certification and AABB accreditation. The Company utilizes proven technologies such as the AXP AutoXpress® Platform and advanced cryopreservation systems, ensuring accuracy, safety, and quality throughout every stage of cell processing and storage. Its services cover a wide range of biological materials, including cord blood, cord tissue, adipose tissue, hair follicles, and Natural Killer (NK) Cells, supporting diverse long-term healthcare and regenerative medicine needs.
When it comes to stem cell banking, trust MEDEZE.
For more information, please visit: https://www.medezegroup.com/th/
IR Press Releases